Kursat Altinbas

Kursat Altinbas

Auto-generated profile, based on publicly available information

Kursat Altinbas

Selçuk University Medical Faculty, Psychiatry, Konya, Turkey

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2016 in Archives of Neuropsychiatry
Verified
Journal Article
Open access
AOAdile Ozkan
Adile Ozkan
KAKursat Altinbas
Kursat Altinbas
EKEmine Rabia Koç
Emine Rabia Koç
HSHalil Murat Sen
Halil Murat Sen
HKHandan Isin Ozisik Karaman
Handan Isin Ozisik Karaman
The aim of the present study was to screen for bipolarity and to investigate the affective temperaments of patients with multiple sclerosis (MS) and the possible association between the clinical and demographic characteristics of MS patients and temperament profiles. A total of 65 patients with MS and 66 healthy volunteers completed the 32-item hypomania checklist (HCl-32), the Mood Disorder Questionnaire (MDQ), and the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego-Autoquestionnaire (TEMPS-A) tests. The HCl-32, MDQ, and TEMPS-A scores were compared between the patients and healthy volunteers. MS patients had significantly higher scores for the depressive, cyclothymic, irritable, and anxious domains of the TEMPS-A scale than the control group, whereas relapsing remitting MS (RRMS) patients had higher MDQ and TEMPS-A hyperthymia scores than secondary progressive MS patients. MS patients who were being treated with interferon beta 1-b therapy had significantly higher MDQ scores than those being treated with interferon beta 1-a, glatiramer acetate, or who were without medication. Expanded Disability Status Scale (EDSS) scores were positively correlated with TEMPS-A depressive and hyperthymic temperaments. Our results suggest that higher scores for affective temperament in MS patients indicate subclinical manifestations of mood disorders. Higher hyperthymia scores and manic symptoms detected in the RRMS group could shed light on the relationship between bipolarity and MS. Thus, the screening of bipolarity and affective temperament profiles in MS patients could help clinicians predict future mood episodes and decrease their impact on disease severity.

13 December 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
MPMELİH PAMUKCU
MELİH PAMUKCU
TDTugba Izci Duran
Tugba Izci Duran
HUHasan Ulusoy
Hasan Ulusoy
KAKürşat Altinbaş
Kürşat Altinbaş
Background/aim: To investigate the correlation between depressive-anxiety symptoms, mixed features, disease activity, and functional status in patients with rheumatoid arthritis (RA) in the light of the shared underlying etiology in both disorders. Materials and methods: The study included 556 patients with RA. RA disease activity was measured using the Disease Activity Score 28-joint count C reactive protein (DAS28-CRP), and the patients were evaluated by a Health Assessment Questionnaire (HAQ). The Hospital Anxiety and Depression Scale (HADS), Mood Disorder Questionnaire (MDQ), and Modified Hypomania Checklist (mHCL) were used to evaluate the mixed depression and bipolarity status of the patients. Results: Of the patients, 430 (77.3%) were female and 126 (22.7%) were male. The median age was 57 years, the median HAQ score was 0.55 points, and the median DAS28-CRP score was 4.1 points. The evaluation of the patients by DAS28-CRP revealed that 58.5% of the patients had moderate and severe disease activity, while only 23.4% of them were in remission. The group using the combination of synthetic disease-modifying anti-rheumatic drugs (sDMARD) and steroid therapy had significantly higher HAD-depression, HAD anxiety, mHCL, DAS28-CRP, HAQ, and MDQ scores than the group using sDMARD alone. The grouping of the patients based on the DAS28-CRP cut-off scores showed that the patients with moderate and severe disease activity had significantly higher HADS, mHCL, MDQ scores than those in remission and those with mild disease activity (p < 0.001). Conclusion: Disease severity and functional status in RA can be affected by comorbid anxiety-depressive and mixed symptoms. Therefore, clinicians should consider screening the depressive-anxiety and mixed mood symptoms of RA patients. Moreover, patients who use steroid therapy are more susceptible to mood symptoms (anxiety, depression, bipolarity), which should also be considered during the follow-up of patients.

1 January 2021 in Archives of Neuropsychiatry
Verified
Journal Article
Open access
KAKürşat Altınbaş
Kürşat Altınbaş
Life time psychiatric comorbidities of bipolar disorders are highly prevalent. Anxiety disorders, alcohol-substance use disorders, obsessive-compulsive disorder and attention deficit and hyperactivity disorder are the most common comorbid psychiatric conditions in bipolar disorders. Psychiatric comorbidity of bipolar disorders is strongly associated with poor treatment response, higher recurrence of mood episodes, suicide attempts, rapid-cycling, worse general functioning and quality of life. Therefore, considering the huge impact of comorbidity on the bipolar disorder illness course, treatment is usually challenging. The primary aim of the treatment in psychiatric comorbidity of bipolar disorder should be mood stabilization and prevention of mood episodes. Then, first line treatment options recommended for the specific psychiatric disorders might be preferred for the treatment of bipolar disorder comorbidity. With this rationale, quetiapine can be listed as a first line treatment for anxiety disorders comorbidity in bipolar disorders while serotonergic antidepressants and olanzapine are recommended as second line options. For the treatment of alcohol-substance use disorders comorbidity, first line mood stabilizers such as valproate and lithium and new generation antipsychotic quetiapine seem to be the leading options. Serotonergic antidepressants for obsessive-compulsive disorder and stimulants for the attention-deficit hyperactivity disorders are the key treatment choices. However, both treatment agents might cause to manic switch and mood destabilization. Thus, clinicians should be aware of these complications when prescribing in bipolar disorders comorbidity.

29 May 2023 in Genel Tıp Dergisi
Verified
Journal Article
Open access
ZÇZeynep Çaliş
Zeynep Çaliş
HBHazan Tomar Bozkurt
Hazan Tomar Bozkurt
KAKürşat Altinbaş
Kürşat Altinbaş
MAMemduha Aydin
Memduha Aydin
Disasters of natural origin, man-made and technological disasters are one of the current issues that always exist in our lives. Disasters are frequently heard on the world agenda and their negative effects on society are discussed. Recently, the Covid-19 epidemic has been on the agenda of the whole world as a global disaster and its effects are still ongoing. The unexpected, sudden, uncontrollable nature of disasters and their threatening to our lives are accepted as a traumatic experience with the effect of psychological destruction. In addition to meeting the basic physical needs of people who have experienced the disaster and are trying to hold on to life after the disaster, psychosocial interventions also have an important place in terms of mental health services. The purpose of this review; It is to explain the psychosocial interventions that can be applied in the emergency periods of disasters and for people who have experienced the disaster.

2 January 2025 in International Journal of Psychiatry in Clinical Practice
Verified
Journal Article
Closed access
RTRukiye Tekdemir
Rukiye Tekdemir
ÖÇÖzge Tan Çamok
Özge Tan Çamok
AKAli Kandeğer
Ali Kandeğer
MAMemduha Aydın
Memduha Aydın
KAKürşat Altınbaş
Kürşat Altınbaş
YSYavuz Selvi
Yavuz Selvi
This study aimed to evaluate the sociodemographic factors, loss-related factors, and adult separation anxiety associated with a diagnosis of Prolonged Grief Disorder (PGD), after controlling for anxiety, depression, and perceived social support during the COVID-19 pandemic in Türkiye. Participants (n=126) completed an online survey that included socio-demographic and loss-related information, as well as the Hospital Anxiety and Depression Scale, Prolonged Grief Disorder Scale-13, Multidimensional Scale of Perceived Social Support, and Adult Separation Anxiety Questionnaire-27. Twelve participants were diagnosed with probable PGD (9.5%). In the linear regression analysis, it was found that when the deceased person was a first-degree relative and younger in age, the presence of guilt, increased separation anxiety, and higher depression scores significantly associated with the severity of PGD. Even when the pandemic is under control, it remains crucial to offer mental health services those who have lost a loved one during the COVID-19 outbreak.

12 April 2021 in Psychiatry and Clinical Psychopharmacology
Verified
Journal Article
Open access
GGGizem Gulpamuk
Gizem Gulpamuk
KAKursat Altinbas
Kursat Altinbas
Bipolar disorder,lithium,ursodeoxycholic acid